DAX slides for seventh straight session, defends 24,000 as oil shock and tech rout collide
Germany's benchmark index closes at 24,018, barely holding the psychologically key level, as rising crude prices, a US tech sell-off, and central bank uncertainty rattle markets.

INDIA —
Key facts
- DAX fell 0.27% to 24,018, its seventh consecutive decline.
- Brent crude surged 2.8% to $111/barrel after UAE said it would leave OPEC.
- OpenAI's revenue miss triggered a sharp sell-off in US tech stocks.
- ECB meets Wednesday; markets now price in two rate hikes by year-end.
- Fed expected to hold rates at 3.5%-3.75% but tone under scrutiny.
- Qiagen plunged nearly 11% after slashing 2026 guidance on weak demand.
- Bayer lost nearly 5% as US Supreme Court case reignites glyphosate concerns.
- DAX closed just below its 200-day moving average of 24,113 points.
Seven-day losing streak tests support
Germany's DAX index dropped for a seventh consecutive session on Tuesday, its longest losing run in months, as a confluence of rising oil prices, a technology rout on Wall Street, and uncertainty over central bank policy decisions battered investor sentiment. The benchmark clawed back from intraday lows to close at 24,018 points, shedding 0.27% and narrowly defending the psychologically important 24,000 level. Since the start of the year, the index has given up roughly 2% of its value, and the technical picture is growing increasingly fragile. The 50-day moving average, currently near 23,890 points, looms as the next critical support, while the DAX slipped just below its 200-day moving average of 24,113 at the close — a threshold closely watched by trend-following traders. The Relative Strength Index stands at 46.6, tilting toward weakness but not yet oversold.
Oil shock and tech rout compound pressure
The primary catalyst for Tuesday's decline came from across the Atlantic. OpenAI's failure to meet its revenue targets triggered a sharp sell-off in US technology stocks, and the negative momentum quickly spread to Frankfurt, compounding existing anxiety about elevated valuations in the tech sector. Meanwhile, energy markets added fresh pressure. Brent crude surged 2.8% to breach $111 a barrel after the United Arab Emirates announced its withdrawal from OPEC, effective May 1. The move stoked fears of further supply disruptions and reignited inflation concerns that had been simmering beneath the surface. Rising bond yields accompanied the oil spike, tightening financial conditions and adding to the headwinds for equities.
Two central bank meetings loom large
Investor nervousness is now squarely focused on the policy decisions due from both the European Central Bank and the Federal Reserve. The ECB meets on Wednesday, and the mood ahead of the gathering has shifted dramatically. Where markets had once priced in rate cuts, traders are now anticipating as many as two rate hikes by year-end, reflecting the stagflationary risk posed by higher energy costs. ECB President Christine Lagarde has kept her cards close to her chest, though reports suggest some members of the Governing Council are already weighing a move. Across the Atlantic, the Fed delivers its own verdict on Wednesday evening. The consensus view is for the central bank to hold rates steady in the 3.5% to 3.75% corridor, but the accompanying statement and press conference will be scrutinized for any shift in tone. The outcome of these two decisions will likely determine whether the DAX can hold above 24,000 or break decisively lower.
Corporate earnings warnings deepen gloom
Corporate news added to the downbeat mood. Qiagen was the worst performer in the index, plunging nearly 11% after the diagnostics specialist slashed its full-year guidance for 2026, citing weak demand. The sharp sell-off wiped out months of gains in a single session. Bayer also came under heavy pressure, losing almost 5% as a case before the US Supreme Court reignited concerns about the glyphosate litigation that has dogged the company for years. The stock has been a persistent underperformer, and Tuesday's move suggests investors see no quick resolution to the legal overhang. Hugo Boss, though not a DAX constituent, made headlines with a profit warning that sent its shares down roughly 10% at the open. The fashion group cautioned that both revenue and operating profit would decline this year, with a recovery not expected before 2027.
Technical indicators flash warning signals
The DAX's slide below its 200-day moving average is a bearish signal for trend-following traders, who often treat such moves as a cue to reduce exposure. The 50-day moving average at 23,890 now represents the next line of defense; a break below that could accelerate selling. With the Relative Strength Index at 46.6, the market is not yet oversold, suggesting further downside may be possible before bargain hunters step in. The combination of a deteriorating technical backdrop, surging energy costs, and policy uncertainty leaves the index in a precarious position.
Outlook hinges on central bank signals
The immediate fate of the DAX rests on the decisions and commentary from the ECB and Fed this week. If both central banks strike a hawkish tone, acknowledging the inflation risks from higher oil prices while signaling a willingness to tighten, equities could come under renewed pressure. Conversely, a dovish tilt might provide temporary relief. Beyond this week, the trajectory of oil prices will be critical. The UAE's exit from OPEC introduces a new source of uncertainty in energy markets, and any further supply disruptions could push Brent higher, deepening the stagflationary scenario that has investors on edge. For now, the DAX is holding by a thread at 24,000, but the forces arrayed against it are mounting.
The bottom line
- DAX fell for a seventh straight session, closing at 24,018 and barely holding 24,000 support.
- Brent crude surged 2.8% to $111/barrel after UAE announced OPEC withdrawal, stoking inflation fears.
- OpenAI's revenue miss triggered a US tech rout that spread to Frankfurt.
- ECB and Fed meetings this week are pivotal; markets now price two ECB rate hikes by year-end.
- Qiagen plunged 11% on guidance cut; Bayer fell 5% on glyphosate litigation; Hugo Boss warned on profit.
- Technical indicators show the DAX below its 200-day moving average, with 23,890 as next support.


Vedanta Demerger: Shares Adjust 63% as Four New Entities Prepare for Listing

BHEL shares surge 13% as Q4 profit triples to Rs 1,290 crore, dividend announced

India slashes Vodafone Idea's AGR liability by 27% to Rs 64,046 crore
